Search research articles
Contact Us
Filters
Showing results (471-480 of 512) with videos related to
Page
of 52
Sort By:
Haematologica
|
October 13, 2022
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
Keith W Pratz, Jason Kaplan, Moshe Levy, et al.
Nature Communications
|
October 30, 2021
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
Verónica Lloréns-Rico, Ann C Gregory, Johan Van Weyenbergh, et al.
Chest
|
October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosis
D Hunter Best, Kelli L Sumner, Eric D Austin, et al.
The American Journal of Medicine
|
November 27, 2012
Adherence to PIOPED II investigators' recommendations for computed tomography pulmonary angiography
Daniel M Adams, Scott M Stevens, Scott C Woller, et al.
Optics Express
|
March 10, 2018
Using X-ray spectroscopy of relativistic laser plasma interaction to reveal parametric decay instabilities: a modeling tool for astrophysics
E Oks, E Dalimier, A Ya Faenov, et al.
ERJ Open Research
|
July 29, 2025
Rare variants in <i>STAB2</i> in patients with chronic thromboembolic pulmonary hypertension
Mark W Dodson, Kristina Allen-Brady, Jeffrey Stevens, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 9, 2008
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial
Frank L Meyskens, Christine E McLaren, Daniel Pelot, et al.
Cell
|
March 15, 2016
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu, Jill C Gregory, Elin Org, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 10, 2006
Genetic association of the serotonin transporter in pulmonary arterial hypertension
Rajiv D Machado, Rolf Koehler, Eric Glissmeyer, et al.
Cancer Medicine
|
March 19, 2024
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors
Dejan Juric, Minal Barve, Ulka Vaishampayan, et al.
Page
of 52
Search research articles
Search
Showing results (471-480 of 512) with videos related to
Sort By:
Page
of 52
Haematologica
|
October 13, 2022
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
Keith W Pratz, Jason Kaplan, Moshe Levy, et al.
Nature Communications
|
October 30, 2021
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
Verónica Lloréns-Rico, Ann C Gregory, Johan Van Weyenbergh, et al.
Chest
|
October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosis
D Hunter Best, Kelli L Sumner, Eric D Austin, et al.
The American Journal of Medicine
|
November 27, 2012
Adherence to PIOPED II investigators' recommendations for computed tomography pulmonary angiography
Daniel M Adams, Scott M Stevens, Scott C Woller, et al.
Optics Express
|
March 10, 2018
Using X-ray spectroscopy of relativistic laser plasma interaction to reveal parametric decay instabilities: a modeling tool for astrophysics
E Oks, E Dalimier, A Ya Faenov, et al.
ERJ Open Research
|
July 29, 2025
Rare variants in <i>STAB2</i> in patients with chronic thromboembolic pulmonary hypertension
Mark W Dodson, Kristina Allen-Brady, Jeffrey Stevens, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 9, 2008
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial
Frank L Meyskens, Christine E McLaren, Daniel Pelot, et al.
Cell
|
March 15, 2016
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu, Jill C Gregory, Elin Org, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 10, 2006
Genetic association of the serotonin transporter in pulmonary arterial hypertension
Rajiv D Machado, Rolf Koehler, Eric Glissmeyer, et al.
Cancer Medicine
|
March 19, 2024
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors
Dejan Juric, Minal Barve, Ulka Vaishampayan, et al.
Page
of 52